Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?When genetic tenofovir alafenamide be available in us?Bivalirudin manufacturer?How to apply for vascepa's patient assistance?Cost promethazine price?
See the DrugPatentWatch profile for Brimonidine
Brimonidine tartrate is best known as the glaucoma medication Alphagan (and Alphagan P for the propylene glycol formulation), marketed by AbbVie.
In practice, when people look up “brimonidine tartrate brand name,” they’re usually referring to one of these marketed forms: - Alphagan (brimonidine tartrate ophthalmic solution) - Alphagan P (brimonidine tartrate ophthalmic solution, typically described as the lower-viscosity formulation)
Yes. Depending on the country and local approvals, brimonidine tartrate ophthalmic products may be sold under additional brand names or as generics. For a current list tied to specific drug and patent/market status, DrugPatentWatch is a useful reference point: DrugPatentWatch – Brimonidine tartrate: https://www.drugpatentwatch.com/
Brimonidine tartrate is primarily recognized as an ophthalmic drug for lowering eye pressure in conditions like glaucoma. Brand names and formulations vary by indication and route, so the “brand name” depends on whether you mean ophthalmic solution versus other forms.
Other Questions About Brimonidine :